샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786578

세계의 분변잠혈 검사 시장

Fecal Occult Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 281 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

분변잠혈 검사 세계 시장은 2030년까지 13억 달러에 달할 전망

2024년에 11억 달러로 추정되는 분변잠혈 검사 세계 시장은 분석 기간인 2024-2030년에 CAGR 3.8%로 성장하여 2030년에는 13억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 Guaiac FOB Stool Test는 CAGR 2.8%를 기록하며 분석 기간 종료시에는 4억 8,860만 달러에 달할 것으로 예측됩니다. Immuno-FOB Agglutination Test(면역-FOB 응집 검사) 분야의 성장률은 분석 기간 동안 CAGR 4.6%로 추정됩니다.

미국 시장은 2억 9,310만 달러로 추정, 중국은 CAGR 6.8%로 성장 예측

미국의 분변잠혈 검사 시장은 2024년에 2억 9,310만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 6.8%로 2030년까지 2억 6,830만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.6%와 2.9%로 예측됩니다. 유럽에서는 독일이 CAGR 2.2%로 성장할 것으로 예측됩니다.

세계의 분변잠혈 검사 시장 - 주요 동향과 촉진요인 정리

분변잠혈 검사가 시장을 주도하는 이유 질병의 조기 발견에 대한 관심이 높아지는 이유

분변잠혈 검사(FOBT)는 대장암, 소화관(GI) 질환, 내출혈을 조기에 발견할 수 있는 중요한 진단 도구가 되고 있습니다. 대장암(CRC), 염증성 장질환(IBD), 소화관 궤양의 유병률이 증가함에 따라 비침습적이고 비용 효율적이며 신속한 선별 검사 방법의 필요성이 증가하고 있으며, 병원, 진단 실험실 및 가정용 검사 키트에서 분변 잠혈 검사의 채택을 촉진하고 있습니다.

기술 혁신은 검사 정확도와 접근성을 어떻게 향상시키고 있는가?

면역화학적 분변잠혈 검사(iFOBT)와 고감도 과이악 기반 FOBT(gFOBT)를 포함한 최신 분변잠혈 검사법은 더 높은 특이성, 더 빠른 결과, 더 나은 환자 순응도를 제공합니다. 또한, AI 기반 진단 알고리즘과 원격의료 플랫폼의 통합으로 원격 검사, 디지털 결과 분석, AI 지원 조기 암 검진이 가능해져 접근성이 더욱 향상되고 있습니다.

정부의 건강검진 프로그램과 의료정책이 시장 성장에 어떤 역할을 할 것인가?

WHO, CDC, European Cancer Prevention Network를 포함한 전 세계 정부 및 보건기관은 분변잠혈 검사를 포함한 정기적인 CRC 검진 프로그램을 추진하고 있습니다. 일본, 영국, 캐나다, 호주 등 의료정책이 국영화된 국가에서는 전 국민을 대상으로 FOBT 검진을 의무화하여 시장 수요를 크게 끌어올리고 있습니다.

분변잠혈 검사 시장의 성장 원동력은?

분변잠혈 검사 시장의 성장은 대장암 환자 증가, 비침습적 진단법 채택 증가, 정부 지원 검진 프로그램 등 여러 요인에 의해 이루어지고 있습니다. 특히 북미, 유럽, 일본의 고령화가 주요 촉진요인이며, 노인은 대장 및 위장 질환의 위험이 높고, 빈번한 FOBT 검진이 필요하기 때문입니다. 또한, 원격의료와 재택 진단 솔루션의 확대로 자가 관리형 FOBT 키트를 보다 쉽게 이용할 수 있게 되어 환자가 병원이나 진료소를 방문하지 않고도 검사를 시행할 수 있게 되었습니다. AI 지원 디지털 병리학 및 액체 생검 기술의 혁신은 검사 감도와 조기 질병 감지 정확도를 더욱 향상시키고, 환자 결과를 개선하고, 의료 시스템의 부담을 줄이고 있습니다. 또한, 주요 헬스케어 시장에서 CRC 검진에 대한 보험급여가 확대되면서 환자들의 경제적 장벽을 낮추고 검진율을 높이는 데 기여하고 있습니다. 예방적 건강관리로의 전환은 조기 암 진단에 대한 투자 증가와 함께 향후 시장 성장을 견인할 것이며, 분변잠혈 검사는 전 세계 대장암 예방 전략의 핵심이 될 것으로 보입니다.

부문

검사(Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test), 최종사용(병원 최종사용, 진단 센터 최종사용, 기타 최종사용)

조사 대상 기업 사례

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Beckman Coulter, Inc.(Danaher Corporation)
  • Biohit Oyj
  • Bio-Rad Laboratories, Inc.
  • EDP Biotech Corporation
  • Eiken Chemical Co., Ltd.
  • EIKEN CHEMICAL CO., LTD.
  • Epigenomics AG
  • Fujirebio Diagnostics, Inc.
  • Helena Laboratories Corporation
  • Meridian Bioscience, Inc.
  • Polymedco CDP, LLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Wondfo Biotech Co., Ltd.

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.14

Global Fecal Occult Testing Market to Reach US$1.3 Billion by 2030

The global market for Fecal Occult Testing estimated at US$1.1 Billion in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2024-2030. Guaiac FOB Stool Test, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$488.6 Million by the end of the analysis period. Growth in the Immuno-FOB Agglutination Test segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$293.1 Million While China is Forecast to Grow at 6.8% CAGR

The Fecal Occult Testing market in the U.S. is estimated at US$293.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$268.3 Million by the year 2030 trailing a CAGR of 6.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 2.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.2% CAGR.

Global Fecal Occult Testing Market - Key Trends & Drivers Summarized

Why Is Fecal Occult Testing Gaining Market Traction? The Growing Focus on Early Disease Detection

Fecal occult blood testing (FOBT) is becoming a key diagnostic tool for detecting colorectal cancer, gastrointestinal (GI) disorders, and internal bleeding at an early stage. The rising prevalence of colorectal cancer (CRC), inflammatory bowel disease (IBD), and gastrointestinal ulcers has heightened the need for non-invasive, cost-effective, and rapid screening methods, driving the adoption of fecal occult tests in hospitals, diagnostic laboratories, and at-home test kits.

How Are Technological Innovations Improving Test Accuracy & Accessibility?

Modern fecal occult testing methods, including immunochemical fecal occult blood tests (iFOBT) and high-sensitivity guaiac-based FOBT (gFOBT), offer higher specificity, faster results, and enhanced patient compliance. Additionally, the integration of AI-driven diagnostic algorithms and telemedicine platforms is enabling remote testing, digital result analysis, and AI-assisted early cancer screening, further enhancing accessibility.

What Role Do Government Screening Programs & Healthcare Policies Play in Market Growth?

Governments and health organizations worldwide, including the WHO, CDC, and European Cancer Prevention Network, are promoting routine CRC screening programs that include fecal occult blood testing. Countries with nationalized healthcare policies, such as Japan, the UK, Canada, and Australia, have mandated population-wide FOBT screenings, significantly boosting market demand.

What’s Driving the Growth of the Fecal Occult Testing Market?

The growth in the fecal occult testing market is driven by multiple factors, including rising colorectal cancer cases, increasing adoption of non-invasive diagnostics, and government-backed screening programs. The aging global population, particularly in North America, Europe, and Japan, is a major driver, as older adults are at a higher risk of colorectal and gastrointestinal diseases, necessitating frequent FOBT screenings. Additionally, the expansion of telehealth and at-home diagnostic solutions is making self-administered FOBT kits more accessible, allowing patients to conduct tests without visiting hospitals or clinics. Innovations in AI-assisted digital pathology and liquid biopsy techniques are further enhancing test sensitivity and early disease detection accuracy, ensuring better patient outcomes and reducing the burden on healthcare systems. Moreover, the growing availability of reimbursement policies for CRC screening in major healthcare markets is lowering financial barriers for patients, encouraging higher screening rates. The shift toward preventive healthcare, coupled with rising investments in early cancer diagnostics, will continue to drive market growth, making fecal occult testing a cornerstone of global colorectal cancer prevention strategies.

SCOPE OF STUDY:

The report analyzes the Fecal Occult Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test (Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test, Immuno-FOB ELISA Test); End-Use (Hospital End-Use, Diagnostic Center End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Alfa Scientific Designs, Inc.
  • Beckman Coulter, Inc. (Danaher Corporation)
  • Biohit Oyj
  • Bio-Rad Laboratories, Inc.
  • EDP Biotech Corporation
  • Eiken Chemical Co., Ltd.
  • EIKEN CHEMICAL CO., LTD.
  • Epigenomics AG
  • Fujirebio Diagnostics, Inc.
  • Helena Laboratories Corporation
  • Meridian Bioscience, Inc.
  • Polymedco CDP, LLC
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Roche Diagnostics
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Wondfo Biotech Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fecal Occult Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Emphasis on Early Colorectal Cancer Detection Drives Demand for Fecal Occult Testing
    • Public Health Screening Programs Propel Uptake of Non-Invasive Testing Technologies
    • Integration of Home-Based Testing Kits Expands Patient Participation in Screening Programs
    • Advancements in Immunochemical Testing Strengthen Accuracy and Adoption of FIT Methods
    • Favorable Reimbursement Policies Across Key Markets Expand Testing Accessibility
    • Aging Global Population Fuels Demand for Age-Specific Colorectal Cancer Screening Tools
    • Increased Awareness Through Government and NGO Campaigns Spurs Preventive Testing
    • Growing Use of Digital Health Platforms Enhances Test Distribution and Follow-Up Compliance
    • Expansion of Telehealth and Remote Monitoring Supports At-Home Sample Collection
    • Healthcare Cost-Containment Strategies Boost Adoption of Low-Cost Diagnostic Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fecal Occult Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fecal Occult Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Guaiac FOB Stool Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Guaiac FOB Stool Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Guaiac FOB Stool Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Immuno-FOB Agglutination Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Immuno-FOB Agglutination Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Immuno-FOB Agglutination Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Lateral Flow Immuno-FOB Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Lateral Flow Immuno-FOB Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Lateral Flow Immuno-FOB Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Immuno-FOB ELISA Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Immuno-FOB ELISA Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Immuno-FOB ELISA Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Center End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Center End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Diagnostic Center End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Fecal Occult Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Fecal Occult Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Fecal Occult Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Fecal Occult Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Fecal Occult Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Fecal Occult Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Fecal Occult Testing by Test - Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Fecal Occult Testing by Test - Percentage Breakdown of Value Sales for Guaiac FOB Stool Test, Immuno-FOB Agglutination Test, Lateral Flow Immuno-FOB Test and Immuno-FOB ELISA Test for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Fecal Occult Testing by End-Use - Hospital End-Use, Diagnostic Center End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Fecal Occult Testing by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Diagnostic Center End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제